Lorrain Daniel S.

CIK 00018615501 companySAN DIEGO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001861550

Recent Transactions

26 trades

Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-03-02$15.01/sh−4,170→ 151,882 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-25$16.01/sh−3,824→ 156,052 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-25$1.01/sh+3,824→ 159,876 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-02-25−3,824→ 67,306 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-02-24−4,300→ 71,130 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-24$1.01/sh+4,300→ 160,352 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-24$16.03/sh−4,300→ 156,052 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-19$16.00/sh−100→ 156,052 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-02-19−100→ 75,430 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-19$1.01/sh+100→ 156,152 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-11$1.01/sh+400→ 156,452 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-11$16.00/sh−400→ 156,052 total
Exercise/Conversion
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-02-11−400→ 75,530 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-03$15.25/sh−1,170→ 156,052 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-02-03$14.82/sh−3,000→ 157,222 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-01-30+160,000→ 160,000 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2026-01-30+6,500→ 6,500 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-01-05$10.35/sh−3,670→ 160,722 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2026-01-05$11.13/sh−500→ 160,222 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-01-31+110,000→ 110,000 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2025-01-31+3,700→ 3,700 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-25$16.02/sh−1,010→ 168,562 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-18$17.05/sh−99→ 169,572 total
Sale
Contineum Therapeutics, Inc.$CTNM
Class A Common Stock
2024-11-18$16.37/sh−6,091→ 169,671 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-05-24+3,700→ 3,700 total
Award
Contineum Therapeutics, Inc.$CTNM
Stock Option (right to buy)
2024-05-24+100,000→ 100,000 total

Companies

Contineum Therapeutics, Inc.
Chief Scientific Officer
$CTNM

Recent Filings

Address

3565 GENERAL ATOMICS COURT, SUITE 200

SAN DIEGO, CA, 92121

View on SEC.gov